Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lasa Supergenerics Limited Call Transcript 2021

Feb 3, 2021

61953_rns_2021-02-03_35f2b4ad-3209-483c-b0d2-5e122e3cd7ac.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [452 x 69] intentionally omitted <==

Ref. No.: LASA/SE/20-21/43

Wednesday, February 03 2021

To,
Corporate Services Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai – 400 001.
BSE CODE –540702
To,
Corporate Services Department
National Stock Exchange of India Limited
“Exchange Plaza”, Plot No. C/1,
G Block Bandra-Kurla Complex,
Bandra (E), Mumbai – 400 051.
NSE CODE: LASA

Dear Sir/Madam,

Sub. Intimation of earnings call on financial results for the quarter year ended December 31, 2020

Dear Sir/Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, February 05, 2021 at 01:00 p.m. IST for discussing the un-audited financial results of the Company for the quarter ended December 2020.

The details of dial number are annexed herewith.

Please take the above on your records.

THANKING YOU YOURS SINCERELY

FOR LASA SUPERGENERICS LIMITED

==> picture [472 x 68] intentionally omitted <==

NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER

==> picture [464 x 18] intentionally omitted <==

==> picture [139 x 80] intentionally omitted <==

`

Lasa Supergenerics Limited

Q3FY21 Earnings Conference Call

Friday, 05[th ] February 2021 at 01:00 p.m.

Wednesday, 03th February 2021 : Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31[st ] 2020 (Q3FY21).

It will organize an earnings conference call on Friday, 05[th] February 2021 @ 01:00 p.m. to discuss the Company’s Q3FY21 financial performance.

Dr. Omkar Herlekar - Chairperson & Managing Director will represent LASA Supergenerics Limited on the call.

The financial results are available on the corporate website - https://lasalabs.com.

DETAILS OF THE CONFERENCE CALL

Timing 01:00p.m. IST on Friday, 05th February 2021
Diamond Pass Click Here
Conference dial-in Primary number 91 22 6280 1554 / 91 22 7115 8374
Local Access Number 91-7045671221
Hong Kong Local Access Number 800964448 / 852 30186877
Singapore Local Access Number 8001012045 / 65 31575746
UK Local Access Number 08081011573 / 44 2034785524
USA Local Access Number 18667462133/ 1 3233868721

About Lasa Supergenerics Limited (www.lasalabs.com/; BSE: 540702; NSE: LASA)

Incorporated in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. Our Company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to countries like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.

For more information contact:

Mr. Hitesh Wadhwani Lasa Supergenerics Ltd. Tel: 7798888147 E-mail: [email protected]